Insulin Resistance in Women with Polycystic Ovary Syndrome: Optimising treatment by Implementing an in vitro Insulin Resistance Organ Culture Model
Abstract
Polycystic ovary syndrome (PCOS) affects about 5-10% of fertile women and is characterised by insulin resistance (IR), dyslipidaemia, hyperandrogenism, and oligomenorrhoe. The metabolic disruption in PCOS women requires treatment to prevent the progression of IR to diabetes and cardiovascular disease. Metformin is currently first line treatment for metabolic/glycemic abnormalities, but lacks beneficial effect on IR PCOS patients with side-effects and cost outweighing benefits. Rosiglitazone has shown to reduce IR,but it was recently withdrawn from the market due to severe side-effects. Basic research into developing optimised drug treatments for IR in PCOS is critical to reducing the development of PCOS associated diabetes and cardiovascular disease. Testing and optimising drugs to reduce IR in PCOS patient samples is difficult due to ethical restrictions. In vitro organ culture models are valuable and reliable. Coronary arteries incubated with high doses of insulin and glucose will be screened for reliable intracellular IR associated biomarkers by western blot and real time PCR analysis. Vascular function by wire-myograph analysis will validate endothelial dysfunction and assess myocardial vascular injury associated responses. The associated response to clinically relevant anti-diabetic treatment options and adjunct therapy will be investigated. Developing a PCOS IR simulated organ culture model will enable us to understand the complicated intracellular signalling…
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.